Health care industry

Eli Lilly LLY cuts 2024 revenue outlook on weight loss drugs

Read more

High-cost weight loss drugs boost nutrition counseling with employers

Read more

Walgreens (WBA) earnings Q1 2025

Read more

Medicare can cover Eli Lilly’s Zepbound for sleep apnea: Health Department

Read more

FDA Zepbound shortage ends, impacts patients, compounding pharmacies

Read more

FDA approves Eli Lilly’s weight loss drug Zepbound for sleep apnea

Read more

Eli Lilly weight loss drug Zepbound no longer in shortage

Read more

How Trump’s policies may affect investors in these 8 market sectors

Read more

Beverly Hills surgeon sues Medtronic for patent infringement

Read more

What Trump’s health pick RFK Jr. could mean for patients, drugmakers

Read more